Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Yong,Li ^[1] ; Huiqin,Huang ^[2] ; Meichen,Jiang ^[3] ; Nanding,Yu ^[1] ; Xiangli,Ye ^[1] ; Zhenghui,Huang ^[1] ; Limin,Chen ^[1]

作者单位： Department of Respiration Medicine, Fujian Medical University Union Hospital, Fuzhou, China. ^[1] Fujian Provincial Key Laboratory of Medical Testing, Fujian Academy of Medical Sciences, Fuzhou, China. ^[2] Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, China. ^[3]

关键词 LUAD hypoxia immune signature tumor microenvironment

DOI 10.3389/fgene.2022.975279

PMID 36263421

发布时间 2022-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in genetics

2022年13卷

975279页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

检索历史清除